Chiron Schedules Special Meeting of Stockholders to Approve Merger With Novartis
02 3월 2006 - 10:30PM
Business Wire
Chiron Corporation (NASDAQ:CHIR) today announced that it will
convene a special meeting of stockholders on Tuesday, April 18,
2006, to vote to approve its proposed merger with Novartis AG. The
meeting will be held at 8:30 a.m. PDT at Chiron's headquarters at
1450 53rd Street, Emeryville, California 94608. Stockholders at the
close of business on the record date of March 3, 2006, will be
eligible to vote at the special meeting. Chiron anticipates filing
its definitive proxy statement with the Securities and Exchange
Commission on or about Friday, March 3, 2006. About Chiron Chiron
delivers innovative and valuable products to protect human health
by advancing pioneering science across the landscape of
biotechnology. The company works to deliver on the limitless
promise of science and make a positive difference in people's
lives. For more information about Chiron, please visit
www.chiron.com. Forward-Looking Statements This news release
contains forward-looking statements, including statements regarding
the date of the special meeting of stockholders and the filing of
the definitive proxy statement with the SEC. These statements are
subject to a number of risks and uncertainties and are subject to
change. There can be no assurance that the special meeting will be
held as described or that the proxy statement will be filed on the
date indicated. Chiron does not undertake an obligation to update
the forward-looking information the company is giving today.
Participants in Solicitation Chiron Corporation and Novartis AG and
Novartis Corporation and their respective directors and executive
officers may be deemed to be participants in the solicitation of
proxies from Chiron stockholders in connection with the merger.
Information about the directors and executive officers of Chiron
and their ownership of Chiron's stock is set forth in the proxy
statement for Chiron's 2005 Annual Meeting of Stockholders.
Investors can obtain more information when the definitive proxy
statement for the proposed merger becomes available. Investors
should read the definitive proxy statement and Schedule 13E-3
carefully before making any voting decision.
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024